| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Dipyridamole measurement |
Component |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Accidental dipyridamole poisoning (disorder) |
Causative agent (attribute) |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
|
| Intentional dipyridamole poisoning |
Causative agent (attribute) |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
|
| intoxication par le dipyridamole d'intention indéterminée |
Causative agent (attribute) |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole adverse reaction |
Causative agent (attribute) |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Allergy to dipyridamole (finding) |
Causative agent (attribute) |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
|
| Dipyridamole overdose |
Causative agent (attribute) |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Accidental dipyridamole overdose |
Causative agent (attribute) |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Intentional dipyridamole overdose |
Causative agent (attribute) |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| surdose de dipyridamole d'intention indéterminée |
Causative agent (attribute) |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
|
| Dipyridamole 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
|
| Dipyridamole 200mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
|
| dipyridamole 5 mg/mL, ampoule de 2 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
|
| Product containing aspirin and dipyridamole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole+aspirin 200mg/25mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
|
| Poisoning by dipyridamole |
Causative agent (attribute) |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
|
| Dipyridamole 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
|
| Product containing dipyridamole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 50mg/5ml oral suspension sugar free |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
|
| Product containing precisely dipyridamole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
|
| Accidental dipyridamole poisoning (disorder) |
Causative agent (attribute) |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Intentional dipyridamole poisoning |
Causative agent (attribute) |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Cardiovascular stress test using the dipyridamole stress test protocol (procedure) |
Using substance (attribute) |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Cardiovascular stress test using the dipyridamole stress test protocol (procedure) |
Using substance (attribute) |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Radionuclide myocardial perfusion stress study using technetium Tc^99m^ methoxyisobutylisonitrile with dipyridamole stress test protocol |
Using substance (attribute) |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Allergy to dipyridamole (finding) |
Causative agent (attribute) |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 75 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole therapy (procedure) |
Direct substance |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
2 |
| Administration of dipyridamole (procedure) |
Direct substance |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Radionuclide imaging of myocardium using technetium (99m-Tc) sestamibi with administration of dipyridamole |
Direct substance |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 200 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 200 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Aspirin 25 mg and dipyridamole 200 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
2 |
| Aspirin 25 mg and dipyridamole 200 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
2 |
| Product containing aspirin and dipyridamole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 75 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Product containing dipyridamole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dipyridamole 10 milligram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dipyridamole 10 milligram/2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dipyridamole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dipyridamole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only aspirin and dipyridamole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only aspirin and dipyridamole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dipyridamole in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Dipyridamole 5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Aspirin 25 mg and dipyridamole 200 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
| Aspirin 25 mg and dipyridamole 200 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dipyridamole (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]